PHOENIX, Oct. 29, 2017 (GLOBE NEWSWIRE) — INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today released the following statement from its president and chief executive officer, Saeed Motahari:
PHOENIX, Oct. 29, 2017 (GLOBE NEWSWIRE) — INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today released the following statement from its president and chief executive officer, Saeed Motahari: